184 related articles for article (PubMed ID: 15887424)
1. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
Hurley DL; Isley WL
Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
[No Abstract] [Full Text] [Related]
2. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
4. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
5. [Recommended LDL value far lower. How does one achieve this goal?].
Einecke D
MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116
[No Abstract] [Full Text] [Related]
6. New developments in pharmacotherapy.
Thompson GR
Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538
[No Abstract] [Full Text] [Related]
7. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
8. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
9. [Statins remain the standard. New methods for lipid lowering therapy].
Aumiller J
MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
[No Abstract] [Full Text] [Related]
10. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
Bruckert E; Giral P; Tellier P
Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
[No Abstract] [Full Text] [Related]
11. Ezetimibe: a turbocharger for the race to reach NCEP LDL goals.
Lee S
S D J Med; 2005 Oct; 58(10):435-6. PubMed ID: 16425945
[No Abstract] [Full Text] [Related]
12. Zetia (ezetimibe).
Kloner RA
Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
[No Abstract] [Full Text] [Related]
13. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Gazzara RA; Brady WE; Palmisano J
Mayo Clin Proc; 2006 Sep; 81(9):1177-85. PubMed ID: 16970214
[TBL] [Abstract][Full Text] [Related]
14. [New results in the management of hypercholesterolemia].
Sármán B
Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
[TBL] [Abstract][Full Text] [Related]
16. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.
Bissonnette S; Habib R; Sampalis F; Boukas S; Sampalis JS;
Can J Cardiol; 2006 Oct; 22(12):1035-44. PubMed ID: 17036098
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy of hypercholesterolemia].
Vanhanen H; Gylling H; Miettinen TA
Duodecim; 2002; 118(19):1967-73. PubMed ID: 12462803
[No Abstract] [Full Text] [Related]
19. Clinical use of ezetimibe.
Cheng AY; Leiter LA
Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors.
Langone AJ; Chuang P
Transplantation; 2006 Mar; 81(5):804-7. PubMed ID: 16534487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
